Briacell Therapeu…
USUSDBriacell Therapeutics Corp (TO:BCT) — Biotechnology: Pharmaceutical Preparations. Nombre de places boursières sur lesquelles les actions de la société sont cotées : 2. Sur cette page : cours et graphique, dividendes, principaux actionnaires et historique du nombre d'actions.
À propos de l'entreprise
- Site web
- briacell.com
- Relations avec les investisseurs
- investors.briacell.com/
- Secteur
- Health Care · Biotechnology: Pharmaceutical Preparations
- Siège social
- WEST VANCOUVER, Canada
- PDG
- William V. Williams
- Actions en circulation
- 8.7 M au 2026-06-09
- Flottant
- 7.86 M
- Capitalisation boursière
- 34.02 M USD
- Initiés
- 0.04%
- Investisseurs institutionnels
- 6.39%
- Secteur d'activité (SIC)
- Pharmaceutical Preparations
- FCF
- —
- Dette
- 0
- Résultats et FCF — pour les 12 mois à 30.04.2026 (dernier rapport de l'entreprise).
Description
BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate the clinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.
Actualités de cette semaine
Aucune actualité au cours de la dernière semaine. Dernière actualité : 24.08.2026.
Principaux actionnaires
| Détenteur | Participation | Actions | Date du rapport |
|---|---|---|---|
| Cable Car Capital, LP | 2.49% | 216 821 | 2026-06-30 |
| Williams (William V) (Di… | ≈1.38% | 119 992 | 2026-07-07 |
| Sabby Management, LLC | 0.93% | 80 721 | 2026-06-30 |
| Iridian Asset Management… | 0.75% | 65 000 | 2026-06-30 |
| UBS Group AG | 0.5% | 43 642 | 2026-06-30 |
| Levin (Gadi) (Senior Off… | ≈0.43% | 37 695 | 2026-07-07 |
| Lopez-Lago (Miguel A) (S… | ≈0.43% | 37 676 | 2026-07-07 |
| HRT Financial LP | 0.4% | 34 904 | 2026-06-30 |
| Jane Street Group, LLC | 0.3% | 26 515 | 2026-06-30 |
| Luminarx Capital Managem… | 0.17% | 15 000 | 2026-06-30 |
| Fidelity Concord Street… | 0.04% | 3 231 | 2026-07-31 |
| National Bank of Canada/… | 0.02% | 1 803 | 2026-06-30 |
| Morgan Stanley | 0.01% | 1 033 | 2026-06-30 |
| Federation Des Caisses D… | 0.01% | 450 | 2026-06-30 |
